Teleflex (NYSE:TFX) Shares Gap Up Following Analyst Upgrade

Key Points

• Upgraded by Raymond James from "market perform" to "outperform," Teleflex's stock gapped up pre-market (closed $110.49 to open $114.54) and Raymond James set a $128 price target.
• The company posted a significant earnings miss — $1.93 EPS vs. $3.73 expected and revenue of $569M vs. $912.57M, down 28.5% year-over-year — and issued FY2026 guidance of $6.25–$6.55 EPS.
• Analyst coverage is mixed (3 Buys, 4 Holds, 2 Sells) with MarketBeat's consensus a "Hold" and a $139 target, while institutional investors own about 95.62% of the stock.

Teleflex Incorporated (NYSE:TFX - Get Free Report)'s stock price gapped up prior to trading on Friday after Raymond James Financial upgraded the stock from a market perform rating to an outperform rating. The stock had previously closed at $110.49, but opened at $114.54. Raymond James Financial now has a $128.00 price target on the stock. Teleflex shares last traded at $114.9940, with a volume of 229,944 shares changing hands.

A number of other equities research analysts have also recently commented on the stock. Zacks Research cut shares of Teleflex from a "hold" rating to a "strong sell" rating in a research report on Monday, March 2nd. Wall Street Zen lowered shares of Teleflex from a "hold" rating to a "sell" rating in a report on Saturday, March 7th. Wells Fargo & Company increased their price objective on Teleflex from $116.00 to $130.00 and gave the company an "equal weight" rating in a report on Friday, February 27th. Needham & Company LLC raised their price objective on Teleflex from $138.00 to $147.00 and gave the stock a "buy" rating in a research report on Thursday, February 26th. Finally, Royal Bank Of Canada boosted their target price on Teleflex from $115.00 to $125.00 and gave the stock a "sector perform" rating in a research note on Friday, February 27th. Three analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $139.00.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently made changes to their positions in the stock. Josh Arnold Investment Consultant LLC purchased a new position in Teleflex in the 4th quarter worth $32,341,000. Invesco Ltd. grew its stake in Teleflex by 3.0% during the 4th quarter. Invesco Ltd. now owns 162,882 shares of the medical technology company's stock valued at $19,878,000 after purchasing an additional 4,807 shares during the last quarter. Alberta Investment Management Corp purchased a new stake in Teleflex during the 4th quarter valued at about $1,318,000. Vident Advisory LLC increased its holdings in shares of Teleflex by 2.8% in the fourth quarter. Vident Advisory LLC now owns 6,992 shares of the medical technology company's stock valued at $853,000 after purchasing an additional 188 shares during the period. Finally, State of Tennessee Department of Treasury raised its stake in shares of Teleflex by 4.7% in the fourth quarter. State of Tennessee Department of Treasury now owns 22,374 shares of the medical technology company's stock worth $2,731,000 after purchasing an additional 998 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $5.08 billion, a PE ratio of -5.59, a PEG ratio of 0.67 and a beta of 0.87. The firm has a 50 day moving average price of $108.80 and a 200-day moving average price of $116.86.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The firm had revenue of $569.00 million during the quarter, compared to analysts' expectations of $912.57 million. During the same quarter in the prior year, the company earned $3.89 EPS. Teleflex's quarterly revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, March 6th. Teleflex's dividend payout ratio is presently -6.62%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.